Here, we subdivided the TCGA samples into gliomas with a wild-type isocitrate dehydrogenase (IDH) gene, with a mutant-type IDH gene, with 1p/19q codeletion, and without 1p/19q codeletion. The gene discussed is IDH2; the disease is central nervous system cancer.